Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
Pharma
Novo, Lilly lost value in Q3 while BMS, Gilead and Sanofi surged
While Eli Lilly and Novo Nordisk experienced market cap declines in Q3, BMS, Gilead and Sanofi saw their value increase, according to GlobalData.
Kevin Dunleavy
Nov 8, 2024 5:00am
Gilead's CAR-T sales stagnate as Trodelvy takes another write-off
Nov 7, 2024 11:16am
Gilead pulls Trodelvy in bladder cancer after trial flop
Oct 18, 2024 10:18am
Lilly, Gilead-Yuhan, Leqembi—Fierce Pharma Asia
Oct 18, 2024 8:20am
GSK bolsters case for long-acting HIV PrEP drug Apretude
Oct 16, 2024 1:26pm
GSK to triple long-acting Apretude supply to boost global access
Oct 7, 2024 10:56am
